Records containing: Muscle Invasive Bladder Cancer (MIBC)

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-03-17
A Multicenter Randomized Controlled Study to Evaluate the Efficacy of Oral Probiotics Combined With PD-1 Monoclonal Antibody and Disitamab Vedotin in Bladder-Preserving Setting for Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer and Low Serum Butyrate
CLINICAL_TRIALS study record update · 2025-12-22
Selective Bladder Preservation After Neoadjuvant Zanidatamab Combined With Tislelizumab and Chemotherapy in Patients With HER2-Positive Muscle-Invasive Bladder Cancer: A Multicenter Study
CLINICAL_TRIALS study record update · 2025-11-20
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy: A Randomized Controlled Trial
CLINICAL_TRIALS study record update · 2025-10-20
A Multicenter, Open-Label, Non-Randomized Phase 1/2 Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Patients With Unresectable Locally Advanced or Metastatic Solid Tumors
CLINICAL_TRIALS study record update · 2025-10-01
Vedisertib (RC48/ADC) Combined With Toripalimab in Bladder-preserving Treatment
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-08-24
Project #1: MRI-guided Bladder Cancer Preservation Program
CLINICAL_TRIALS study record update · 2025-07-24
Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer